These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22948718)

  • 21. Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats.
    Revermann M; Barbosa-Sicard E; Dony E; Schermuly RT; Morisseau C; Geisslinger G; Fleming I; Hammock BD; Brandes RP
    J Hypertens; 2009 Feb; 27(2):322-31. PubMed ID: 19226702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble epoxide hydrolase activation by S-nitrosation contributes to cardiac ischemia-reperfusion injury.
    Ding Y; Li Y; Zhang X; He J; Lu D; Fang X; Wang Y; Wang J; Zhang Y; Qiao X; Gan LM; Chen C; Zhu Y
    J Mol Cell Cardiol; 2017 Sep; 110():70-79. PubMed ID: 28736260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knockout of angiotensin 1-7 receptor Mas worsens the course of two-kidney, one-clip Goldblatt hypertension: roles of nitric oxide deficiency and enhanced vascular responsiveness to angiotensin II.
    Rakušan D; Bürgelová M; Vaněčková I; Vaňourková Z; Husková Z; Skaroupková P; Mrázová I; Opočenský M; Kramer HJ; Netuka I; Malý J; Alenina N; Bader M; Santos RA; Cervenka L
    Kidney Blood Press Res; 2010; 33(6):476-88. PubMed ID: 21071955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of eNOS prevents the development of renovascular hypertension in mice.
    Gava AL; Peotta VA; Cabral AM; Vasquez EC; Meyrelles SS
    Can J Physiol Pharmacol; 2008 Jul; 86(7):458-64. PubMed ID: 18641695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of soluble epoxide hydrolase reduces portal pressure by protecting mesenteric artery myogenic responses in cirrhotic rats.
    Huang Y; Qin J; Sun D; Jiang H; Zheng L; He Y; Gui L; Qian B; Zhang C; Luo M
    Prostaglandins Other Lipid Mediat; 2017 Jul; 131():17-24. PubMed ID: 28473204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meloxicam fails to augment the reno-protective effects of soluble epoxide hydrolase inhibition in streptozotocin-induced diabetic rats via increased 20-HETE levels.
    Katary MM; Pye C; Elmarakby AA
    Prostaglandins Other Lipid Mediat; 2017 Sep; 132():3-11. PubMed ID: 27596333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension.
    Jung O; Brandes RP; Kim IH; Schweda F; Schmidt R; Hammock BD; Busse R; Fleming I
    Hypertension; 2005 Apr; 45(4):759-65. PubMed ID: 15699457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble epoxide hydrolase gene deficiency or inhibition attenuates chronic active inflammatory bowel disease in IL-10(-/-) mice.
    Zhang W; Yang AL; Liao J; Li H; Dong H; Chung YT; Bai H; Matkowskyj KA; Hammock BD; Yang GY
    Dig Dis Sci; 2012 Oct; 57(10):2580-91. PubMed ID: 22588244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble epoxide hydrolase deficiency attenuates neointima formation in the femoral cuff model of hyperlipidemic mice.
    Revermann M; Schloss M; Barbosa-Sicard E; Mieth A; Liebner S; Morisseau C; Geisslinger G; Schermuly RT; Fleming I; Hammock BD; Brandes RP
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):909-14. PubMed ID: 20224052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble epoxide hydrolase in the generation and maintenance of high blood pressure in spontaneously hypertensive rats.
    Koeners MP; Wesseling S; Ulu A; Sepúlveda RL; Morisseau C; Braam B; Hammock BD; Joles JA
    Am J Physiol Endocrinol Metab; 2011 Apr; 300(4):E691-8. PubMed ID: 21266668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of phosphatase activity of soluble epoxide hydrolase in regulating simvastatin-activated endothelial nitric oxide synthase.
    Hou HH; Liao YJ; Hsiao SH; Shyue SK; Lee TS
    Sci Rep; 2015 Aug; 5():13524. PubMed ID: 26304753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased availability of nitric oxide leads to enhanced nitric oxide dependency of tubuloglomerular feedback in the contralateral kidney of rats with 2-kidney, 1-clip Goldblatt hypertension.
    Turkstra E; Boer P; Braam B; Koomans HA
    Hypertension; 1999 Oct; 34(4 Pt 1):679-84. PubMed ID: 10523346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuation of cisplatin-induced renal injury by inhibition of soluble epoxide hydrolase involves nuclear factor κB signaling.
    Liu Y; Webb HK; Fukushima H; Micheli J; Markova S; Olson JL; Kroetz DL
    J Pharmacol Exp Ther; 2012 Jun; 341(3):725-34. PubMed ID: 22414856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Female-favorable attenuation of coronary myogenic constriction via reciprocal activations of epoxyeicosatrienoic acids and nitric oxide.
    Froogh G; Qin J; Kandhi S; Le Y; Jiang H; Luo M; Sun D; Huang A
    Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1448-54. PubMed ID: 27016584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of soluble epoxide hydrolase in mice promotes reverse cholesterol transport and regression of atherosclerosis.
    Shen L; Peng H; Peng R; Fan Q; Zhao S; Xu D; Morisseau C; Chiamvimonvat N; Hammock BD
    Atherosclerosis; 2015 Apr; 239(2):557-65. PubMed ID: 25733327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble epoxide hydrolase null mice exhibit female and male differences in regulation of vascular homeostasis.
    Vanella L; Canestraro M; Lee CR; Cao J; Zeldin DC; Schwartzman ML; Abraham NG
    Prostaglandins Other Lipid Mediat; 2015 Jul; 120():139-47. PubMed ID: 25908301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced coronary reactive hyperemia in mice was reversed by the soluble epoxide hydrolase inhibitor (t-AUCB): Role of adenosine A
    Hanif A; Edin ML; Zeldin DC; Morisseau C; Falck JR; Ledent C; Tilley SL; Nayeem MA
    Prostaglandins Other Lipid Mediat; 2017 Jul; 131():83-95. PubMed ID: 28890385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble epoxide hydrolase: gene structure, expression and deletion.
    Harris TR; Hammock BD
    Gene; 2013 Sep; 526(2):61-74. PubMed ID: 23701967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orally active epoxyeicosatrienoic acid analog does not exhibit antihypertensive and reno- or cardioprotective actions in two-kidney, one-clip Goldblatt hypertensive rats.
    Alánová P; Husková Z; Kopkan L; Sporková A; Jíchová Š; Neckář J; Imig JD; Klevstig M; Kolář F; Rami Reddy N; Falck JR; Sadowski J; Nishiyama A; Kramer HJ; Melenovský V; Červenková L; Kujal P; Vernerová Z; Červenka L
    Vascul Pharmacol; 2015 Oct; 73():45-56. PubMed ID: 26304700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting arachidonic acid pathway to prevent programmed hypertension in maternal fructose-fed male adult rat offspring.
    Tain YL; Lee WC; Wu KLH; Leu S; Chan JYH
    J Nutr Biochem; 2016 Dec; 38():86-92. PubMed ID: 27732913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.